Clinical trials show users lose an average of 12–15% of their
total body weight within 6–12 months on semaglutide therapy.
Semaglutide/B12
Combination therapy leads to weight loss of up to 15% of total
body weight, with 70% of users also reporting higher energy and improved mood compared
to semaglutide alone.
Tirzepatide
Major clinical studies demonstrate up to 22.5% reduction in
total body weight after 72 weeks of tirzepatide treatment.
AOD-9604
AOD-9604 has been shown to reduce body fat by up to 10% in
stubborn areas over 12 weeks, with no effect on blood sugar or muscle mass.
Enclomiphene
Men using enclomiphene saw average testosterone increases of
200–300 ng/dL and up to 2–3x improvement in sperm count within 3 months.
SLU-PP-332
Switches on exercise-like metabolic programs (ERR/PGC-1α),
increasing fat oxidation and mitochondrial efficiency so
muscles behave as if they’re in training—supporting endurance and smoother recovery between
sessions.
Methylene Blue (capsule/IM/nasal)
Cognitive and cellular-energy support for clear, steady thinking
and resilient performance.
Never Miss an IVÉ Moment
Get exclusive wellness tips, member perks,
and the latest IVÉ updates—delivered right to your inbox.
